Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary treatment for Hyperekplexia focuses on the use of clonazepam to manage excessive startle responses and reduce the risk of apnea or falls. Treatment is highly individualized, and clinical management often requires a multidisciplinary team to address both neurological symptoms and developmental needs. What are the first-line medical treatments for Hyperekplexia? The gold standard for managing Hyperekplexia is the administration of benzodiazepines, most commonly clonazepam (Klonopin).
2 people with Hyperekplexia have shared their first-person experience on this question at DiseaseMaps.
The primary treatment for Hyperekplexia focuses on the use of clonazepam to manage excessive startle responses and reduce the risk of apnea or falls. Treatment is highly individualized, and clinical management often requires a multidisciplinary team to address both neurological symptoms and developmental needs.
The gold standard for managing Hyperekplexia is the administration of benzodiazepines, most commonly clonazepam (Klonopin). This medication acts on the inhibitory neurotransmitter glycine, which is often impaired in patients with Hyperekplexia. By enhancing the inhibitory pathways in the central nervous system, clonazepam helps dampen the exaggerated startle reflex. Because Hyperekplexia presents with varying degrees of severity, clinicians must carefully individualize dosing to balance symptom control with potential side effects such as drowsiness or muscle weakness.
Beyond medication, managing Hyperekplexia involves protective strategies and physical support. These include:
Due to the complexity of Hyperekplexia, a multidisciplinary approach is recommended. Your care team should ideally include a pediatric or adult neurologist, a clinical geneticist for family planning and counseling, and a physical therapist. For our 56 community members at DiseaseMaps.org living with Hyperekplexia, coordinating care between these specialists is vital for managing long-term outcomes.
Research into Hyperekplexia is ongoing, focusing on genetic therapies and drugs that target specific glycine receptor mutations. While no cure currently exists, clinical trials often investigate alternative compounds for patients who do not respond adequately to clonazepam. Participation in registries and clinical studies remains the best way to help researchers understand the natural history of this rare condition.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with your healthcare provider for diagnosis and treatment decisions.